# Chemotherapy Before & After Surgery in Patients With Resectable Gallbladder Cancer

> **NCT03579758** · PHASE3 · WITHDRAWN · sponsor: **Emory University**

## Conditions studied

- Stage I Gallbladder Cancer AJCC v8
- Stage II Gallbladder Cancer AJCC v8
- Stage IIA Gallbladder Cancer AJCC v8
- Stage IIB Gallbladder Cancer AJCC v8
- Stage III Gallbladder Cancer AJCC v8
- Stage IIIA Gallbladder Cancer AJCC v8
- Stage IIIB Gallbladder Cancer AJCC v8

## Interventions

- **DRUG:** Capecitabine
- **DRUG:** Cisplatin
- **DRUG:** Gemcitabine

## Key facts

- **NCT ID:** NCT03579758
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-04-03
- **Primary completion:** 2020-06-01
- **Final completion:** 2020-06-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** This trial will open as an NCTN trial.
- **Last updated:** 2020-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03579758

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03579758, "Chemotherapy Before & After Surgery in Patients With Resectable Gallbladder Cancer". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT03579758. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*